CHEMED CORPORATION Proceeds from Long-term Lines of Credit
CHEMED CORPORATION (CHE) reported Proceeds from Long-term Lines of Credit of $491.48 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromLongTermLinesOfCredit · last filed 2026-07-31
- CHEMED CORPORATION proceeds from long-term lines of credit for the quarter ending 2026-06-30 was $356.00M.
- CHEMED CORPORATION proceeds from long-term lines of credit for the quarter ending 2026-03-31 was $135.48M.
- CHEMED CORPORATION proceeds from long-term lines of credit for the quarter ending 2022-12-31 was $5.30M, a 97.46% decline year-over-year.
- CHEMED CORPORATION proceeds from long-term lines of credit for the quarter ending 2022-09-30 was $21.40M.
- CHEMED CORPORATION proceeds from long-term lines of credit for fiscal 2022 was $121.80M, a 42.08% decline from fiscal 2021.
- CHEMED CORPORATION proceeds from long-term lines of credit for fiscal 2021 was $210.30M, a 20.24% increase from fiscal 2020.
- CHEMED CORPORATION proceeds from long-term lines of credit for fiscal 2020 was $174.90M, a 63.78% decline from fiscal 2019.
- CHEMED CORPORATION proceeds from long-term lines of credit for fiscal 2019 was $482.90M, a 2.84% increase from fiscal 2018.
| Period end | Proceeds from Long-term Lines of Credit 3 month | Proceeds from Long-term Lines of Credit 6 month | Proceeds from Long-term Lines of Credit 9 month | Proceeds from Long-term Lines of Credit 12 month | Proceeds from Long-term Lines of Credit 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $356.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | $491.48M 10-Q · filed 2026-07-31 | |||
| 2026-03-31 | $135.48M 10-Q · filed 2026-04-28 | ||||
| 2022-12-31 | $5.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $26.70M derived: sum of 2 quarters · filed 2025-02-28 | $100.30M derived: sum of 3 quarters · filed 2025-02-28 | $121.80M 10-K · filed 2025-02-28 | |
| 2022-09-30 | $21.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27 | $95.00M derived: sum of 2 quarters · filed 2023-10-27 | $116.50M 10-Q · filed 2023-10-27 | $325.30M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-06-30 | $73.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | $95.10M 10-Q · filed 2023-07-28 | $303.90M derived: sum of 3 quarters · filed 2024-02-29 | ||
| 2022-03-31 | $21.50M 10-Q · filed 2023-04-28 | $230.30M derived: sum of 2 quarters · filed 2024-02-29 | |||
| 2021-12-31 | $208.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $210.30M 10-K · filed 2024-02-29 | |||
| 2021-09-30 | $1.50M 10-Q · filed 2022-11-02 | ||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $0.00 derived: sum of 2 quarters · filed 2023-02-27 | $800.00K derived: sum of 3 quarters · filed 2023-02-27 | $174.90M 10-K · filed 2023-02-27 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-01 | $800.00K derived: sum of 2 quarters · filed 2021-11-01 | $174.90M 10-Q · filed 2021-11-01 | $257.10M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-06-30 | $800.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $174.90M 10-Q · filed 2021-07-30 | $257.10M derived: sum of 3 quarters · filed 2022-02-28 | $435.00M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-03-31 | $174.10M 10-Q · filed 2021-04-30 | $256.30M derived: sum of 2 quarters · filed 2022-02-28 | $434.20M derived: sum of 3 quarters · filed 2022-02-28 | $531.90M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2019-12-31 | $82.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $260.10M derived: sum of 2 quarters · filed 2022-02-28 | $357.80M derived: sum of 3 quarters · filed 2022-02-28 | $482.90M 10-K · filed 2022-02-28 | |
| 2019-09-30 | $177.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $275.60M derived: sum of 2 quarters · filed 2020-11-04 | $400.70M 10-Q · filed 2020-11-04 | $442.10M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2019-06-30 | $97.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $222.80M 10-Q · filed 2020-07-31 | $264.20M derived: sum of 3 quarters · filed 2021-02-26 | $334.00M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2019-03-31 | $125.10M 10-Q · filed 2020-05-01 | $166.50M derived: sum of 2 quarters · filed 2021-02-26 | $236.30M derived: sum of 3 quarters · filed 2021-02-26 | $460.35M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2018-12-31 | $41.40M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $111.20M derived: sum of 2 quarters · filed 2021-02-26 | $335.25M derived: sum of 3 quarters · filed 2021-02-26 | $469.55M 10-K · filed 2021-02-26 | |
| 2018-09-30 | $69.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $293.85M derived: sum of 2 quarters · filed 2019-11-04 | $428.15M 10-Q · filed 2019-11-04 | $456.80M derived: sum of 4 quarters · filed 2020-02-26 | |
| 2018-06-30 | $224.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $358.35M 10-Q · filed 2019-07-31 | $387.00M derived: sum of 3 quarters · filed 2020-02-26 | $434.90M derived: sum of 4 quarters · filed 2020-02-26 | |
| 2018-03-31 | $134.30M 10-Q · filed 2019-05-02 | $162.95M derived: sum of 2 quarters · filed 2020-02-26 | $210.85M derived: sum of 3 quarters · filed 2020-02-26 | $230.65M derived: sum of 4 quarters · filed 2020-02-26 | |
| 2017-12-31 | $28.65M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $76.55M derived: sum of 2 quarters · filed 2020-02-26 | $96.35M derived: sum of 3 quarters · filed 2020-02-26 | $212.35M 10-K · filed 2020-02-26 | $261.65M 10-K · filed 2018-02-26 |
| 2017-09-30 | $47.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | $67.70M derived: sum of 2 quarters · filed 2018-11-02 | $183.70M 10-Q · filed 2018-11-02 | $200.55M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2017-06-30 | $19.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-30 | $135.80M 10-Q · filed 2018-07-30 | $152.65M derived: sum of 3 quarters · filed 2019-02-27 | $170.45M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2017-03-31 | $116.00M 10-Q · filed 2018-04-27 | $132.85M derived: sum of 2 quarters · filed 2019-02-27 | $150.65M derived: sum of 3 quarters · filed 2019-02-27 | $184.05M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2016-12-31 | $16.85M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $34.65M derived: sum of 2 quarters · filed 2019-02-27 | $68.05M derived: sum of 3 quarters · filed 2019-02-27 | $127.05M 10-K · filed 2019-02-27 | $184.55M 10-K · filed 2017-02-27 |
| 2016-09-30 | $17.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27 | $51.20M derived: sum of 2 quarters · filed 2017-10-27 | $110.20M 10-Q · filed 2017-10-27 | $110.20M derived: sum of 4 quarters · filed 2018-02-26 | |
| 2016-06-30 | $33.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-31 | $92.40M 10-Q · filed 2017-07-31 | $92.40M derived: sum of 3 quarters · filed 2018-02-26 | $92.40M derived: sum of 4 quarters · filed 2018-02-26 | |
| 2016-03-31 | $59.00M 10-Q · filed 2017-04-28 | $59.00M derived: sum of 2 quarters · filed 2018-02-26 | $59.00M derived: sum of 3 quarters · filed 2018-02-26 | $125.00M derived: sum of 4 quarters · filed 2018-02-26 | |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $0.00 derived: sum of 2 quarters · filed 2018-02-26 | $66.00M derived: sum of 3 quarters · filed 2018-02-26 | $103.20M 10-K · filed 2018-02-26 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $66.00M derived: sum of 2 quarters · filed 2016-11-01 | $103.20M 10-Q · filed 2016-11-01 | $180.95M derived: sum of 4 quarters · filed 2017-02-27 | |
| 2015-06-30 | $66.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29 | $103.20M 10-Q · filed 2016-07-29 | $180.95M derived: sum of 3 quarters · filed 2017-02-27 | $244.05M derived: sum of 4 quarters · filed 2017-02-27 | |
| 2015-03-31 | $37.20M 10-Q · filed 2016-05-02 | $114.95M derived: sum of 2 quarters · filed 2017-02-27 | $178.05M derived: sum of 3 quarters · filed 2017-02-27 | ||
| 2014-12-31 | $77.75M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $140.85M derived: sum of 2 quarters · filed 2017-02-27 | $386.35M 10-K · filed 2017-02-27 | ||
| 2014-09-30 | $63.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30 | $308.60M 10-Q · filed 2015-10-30 | |||
| 2014-06-30 | $245.50M 10-Q · filed 2015-07-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Option Care Health, Inc. (OPCH) | United States | $3.602B | 20.52 |
| Aveanna Healthcare Holdings, Inc. (AVAH) | United States | $2.703B | 7.22 |
| Addus HomeCare Corp (ADUS) | United States | $2.129B | 17.80 |
| BrightSpring Health Services, Inc. (BTSG) | United States | $11.078B | 37.65 |
| AdaptHealth Corp. (AHCO) | United States | $0.759B | -6.22 |